erapy (Results of a VA Cooperative Study[J]. Am J Cardiol,1998,82:1445-1450.
[3]Pitt B,Waters D, Brown WV, et al. Aggressive lipid_lowering therapy compared with angioplasty in stable coronary disease[J]. N Engl J Med, 1999,341:70-76.
[4]Henderson RA, Pocock SJ, Clayton TC, et al.Seven_year outcome in the RITA_2 Trial:Coronary angioplasty versus medical therapy[J]. J Am Coll Cardiol,2003,42:1161-1170.
[5]Hueb W, Lopes NH, Gersh BJ, et al. Five_Year follow_up of the medicine, angioplasty, or surgery study (MASS II):A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease[J]. Circulation,2007,115:1082-1089.
[6]Boden WE, 0’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease[J]. N Engl J Med,2007,356:1503-1516.
[7]Hochman JS, Lamas GA, Buller CE, et al.Coronary intervention for persistent occlusion after myocardial infarction[J]. N Engl J Med, 2006,355:2395-2407.
[8]TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary_artery disease(TIME):a randomised trial[J]. Lancet, 2001,358:951-957.
[9]Suttorp MJ, Laarman GJ, Rahel BM, et al. Primary stenting of occluded native coronary arteries II (PRISON II).A randomized comparison of bare metal stem implantation with sirolimus_eluting stent implantation for the treatment of total coronary occlusions[J]. Circulation, 2006,114:921-928.
上一页 [1] [2] [3]